Effectiveness of perampanel in managing chronic pain caused by the complex regional pain syndrome

Efficacy and safety of adjunctive perampanel 4 mg/d for the treatment of focal seizures: A pooled post hoc analysis of four randomized, double‐blind, phase III studies

(2020) Bernhard J. Steinhoff et al.   EPILEPSIA

Intrathecally administered perampanel alleviates neuropathic and inflammatory pain in rats

(2020) Koji Hara et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Perampanel inhibits calcitonin gene-related peptide release from rat brainstem in vitro

(2018) Giuseppe Tringali et al.   JOURNAL OF HEADACHE AND PAIN

Glutamate as a neurotransmitter in the healthy brain

(2014) Y. Zhou et al.   JOURNAL OF NEURAL TRANSMISSION

Perampanel, a novel, non-competitive, selective AMPA receptor antagonist as adjunctive therapy for treatment-resistant partial-onset seizures

(2012) Ivan Rektor   EXPERT OPINION ON PHARMACOTHERAPY

NGX426, an Oral AMPA-Kainate Antagonist, Is Effective in Human Capsaicin-Induced Pain and Hyperalgesia

(2012) Mark S. Wallace et al.   PAIN MEDICINE

Regulation of AMPA Receptors in Spinal Nociception

(2010) Yun Wang et al.   Molecular Pain

Validation of proposed diagnostic criteria (the “Budapest Criteria”) for Complex Regional Pain Syndrome

(2010) Norman R. Harden et al.   PAIN

Central sensitization: Implications for the diagnosis and treatment of pain

(2010) Clifford J. Woolf   PAIN

The Efficacy of the AMPA Receptor Antagonist NS1209 and Lidocaine in Nerve Injury Pain: A Randomized, Double-Blind, Placebo-Controlled, Three-Way Crossover Study

(2009) Lise Gormsen et al.   ANESTHESIA AND ANALGESIA